Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07169760 · ClinicalTrials.gov registry record · Phase 4
R61/33 - VR Study Phase 4
A Phase 4 study of Attention Deficit Hyperactivity Disorder, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 252
- Enrollment target
- 2
- Study locations
NCT07169760: Recruiting Phase 4 study of Attention Deficit Hyperactivity Disorder, sponsored by Rutgers, The State University of New Jersey.
NCT07169760 is a Phase 4 study of Attention Deficit Hyperactivity Disorder that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 252 participants, above the 214-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (18% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07169760, a Phase 4 study of Attention Deficit Hyperactivity Disorder, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 252 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedback about levels of focus to a control group. The main question is whether participants demonstrate significantly improved concentration while completing homework and studying in virtual reality and whether they enjoy and prefer working in a virtual reality environment. Concentration is measured both through participant report and also using keyboard and mouse click data to assess work productivity objectively.
Primary Outcome
Participants rate how concentrated they were to complete work and study
Conditions Studied
Interventions
- BEHAVIORAL Meta Quest 3 VR Headset with noise cancelling headphones
Study Locations (2)
Louisiana
- Louisiana State University - Baton Rouge
New Jersey
- Rutgers University - New Brunswick - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2025-09-09 |
| Est. Completion | 2030-12 |
| Phase | Phase 4 |
What NCT07169760 shows while recruiting
NCT07169760 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, above the 214-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (18% higher).
The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Meta Quest 3 VR Headset with noise cancelling headphones is the first listed.
NCT07169760 reports a single indexed study location in Louisiana, New Jersey.
Frequently Asked Questions
What is clinical trial NCT07169760 about?
NCT07169760 is a clinical study titled "R61/33 - VR Study Phase 4". The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the imp...
What is the current status of trial NCT07169760?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 252 participants. The study started on 2025-09-09. Estimated completion is 2030-12.
What conditions does trial NCT07169760 study?
This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.
What interventions are being tested in trial NCT07169760?
The interventions under investigation include: Meta Quest 3 VR Headset with noise cancelling headphones (BEHAVIORAL).
Who is sponsoring clinical trial NCT07169760?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07169760 being conducted?
This trial has 2 study locations across Louisiana, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Hyperactivity Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07169760's enrollment target sits among peer trials
252 25th of 102 higher than 78 of 102 other Attention Deficit Hyperactivity Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
RECRUITING · Phase 4
-
A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
RECRUITING · Phase 4
-
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
RECRUITING · Phase 4
-
Stimulant Effects on Disruptive Behavior
RECRUITING · Phase 4
-
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RECRUITING · Phase 4
-
An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI